Harbour Investments, Inc. Genprex, Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$1.21 - $2.7 $2,513 - $5,607	-2,077 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.59 - $3.36 $4,814 - $6,246	1,859 Added 852.75%	2,077 $6,000
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $18 - $29	6 Added 2.83%	218 $1,000
Q1 2021 Aug 17, 2021	BUY	$3.66 - $7.67 $775 - $1,626	212 New	212 $1,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $112M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.